# Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T

> **NCT04749160** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 26 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DEVICE:** Connected device

## Key facts

- **NCT ID:** NCT04749160
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-04
- **Primary completion:** 2022-02-20
- **Final completion:** 2022-02-20
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04749160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04749160, "Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04749160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*